Enveric Biosciences Inc vs Johnson Controls International PLC — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Johnson Controls International PLC trades at $155.29 (market cap $93.74B). The key difference: Johnson Controls International PLC is far larger — about 15119.4× Enveric Biosciences Inc's market cap, and Johnson Controls International PLC pays a 1.03% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | JCI | |
|---|---|---|
Market Cap | $6.20M | $93.74B |
Sector | Health | Industrials |
52-Week High | $17.40 | $154.76 |
52-Week Low | $1.27 | $103.52 |
Enterprise Value | $1.30M | $102.58B |
Dividend Yield | — | 1.03% |
Trailing returns across standard periods
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Johnson Controls manufactures, installs, and services HVAC systems, building management systems and controls, industrial refrigeration systems, and fire and security solutions. Commercial HVAC accounts for about 40% of sales, fire and security also represents 40% of sales, and residential HVAC, industrial refrigeration, and other solutions account for the remaining 20% of revenue. In fiscal 2021, Johnson Controls generated over $23.5 billion in revenue.
Read more on JCI →